Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial

JOURNAL ARTICLE published February 2010 in The Lancet Oncology

Authors: Tetsuya Mitsudomi | Satoshi Morita | Yasushi Yatabe | Shunichi Negoro | Isamu Okamoto | Junji Tsurutani | Takashi Seto | Miyako Satouchi | Hirohito Tada | Tomonori Hirashima | Kazuhiro Asami | Nobuyuki Katakami | Minoru Takada | Hiroshige Yoshioka | Kazuhiko Shibata | Shinzoh Kudoh | Eiji Shimizu | Hiroshi Saito | Shinichi Toyooka | Kazuhiko Nakagawa | Masahiro Fukuoka